Copyright Reports & Markets. All rights reserved.

Global Tissue Engineered Skin Substitutes Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Tissue Engineered Skin Substitutes Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Tissue Engineered Skin Substitutes Market Size Growth Rate by Product
      • 1.4.2 Acellular
      • 1.4.3 Cellular Allogeneic
      • 1.4.4 Cellular Autologous
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Tissue Engineered Skin Substitutes Market Size Growth Rate by End User
      • 1.5.2 Burn Injury
      • 1.5.3 Diabetic
      • 1.5.4 Vascular Ulcer
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Tissue Engineered Skin Substitutes Market Size
      • 2.1.1 Global Tissue Engineered Skin Substitutes Revenue 2014-2025
      • 2.1.2 Global Tissue Engineered Skin Substitutes Sales 2014-2025
    • 2.2 Tissue Engineered Skin Substitutes Growth Rate by Regions
      • 2.2.1 Global Tissue Engineered Skin Substitutes Sales by Regions
      • 2.2.2 Global Tissue Engineered Skin Substitutes Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Tissue Engineered Skin Substitutes Sales by Manufacturers
      • 3.1.1 Tissue Engineered Skin Substitutes Sales by Manufacturers
      • 3.1.2 Tissue Engineered Skin Substitutes Sales Market Share by Manufacturers
      • 3.1.3 Global Tissue Engineered Skin Substitutes Market Concentration Ratio (CR5 and HHI)
    • 3.2 Tissue Engineered Skin Substitutes Revenue by Manufacturers
      • 3.2.1 Tissue Engineered Skin Substitutes Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tissue Engineered Skin Substitutes Revenue Share by Manufacturers (2014-2019)
    • 3.3 Tissue Engineered Skin Substitutes Price by Manufacturers
    • 3.4 Tissue Engineered Skin Substitutes Manufacturing Base Distribution, Product Types
      • 3.4.1 Tissue Engineered Skin Substitutes Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Tissue Engineered Skin Substitutes Product Type
      • 3.4.3 Date of International Manufacturers Enter into Tissue Engineered Skin Substitutes Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Tissue Engineered Skin Substitutes Sales by Product
    • 4.2 Global Tissue Engineered Skin Substitutes Revenue by Product
    • 4.3 Tissue Engineered Skin Substitutes Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Tissue Engineered Skin Substitutes Breakdown Data by End User

    6 North America

    • 6.1 North America Tissue Engineered Skin Substitutes by Countries
      • 6.1.1 North America Tissue Engineered Skin Substitutes Sales by Countries
      • 6.1.2 North America Tissue Engineered Skin Substitutes Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Tissue Engineered Skin Substitutes by Product
    • 6.3 North America Tissue Engineered Skin Substitutes by End User

    7 Europe

    • 7.1 Europe Tissue Engineered Skin Substitutes by Countries
      • 7.1.1 Europe Tissue Engineered Skin Substitutes Sales by Countries
      • 7.1.2 Europe Tissue Engineered Skin Substitutes Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Tissue Engineered Skin Substitutes by Product
    • 7.3 Europe Tissue Engineered Skin Substitutes by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Tissue Engineered Skin Substitutes by Countries
      • 8.1.1 Asia Pacific Tissue Engineered Skin Substitutes Sales by Countries
      • 8.1.2 Asia Pacific Tissue Engineered Skin Substitutes Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Tissue Engineered Skin Substitutes by Product
    • 8.3 Asia Pacific Tissue Engineered Skin Substitutes by End User

    9 Central & South America

    • 9.1 Central & South America Tissue Engineered Skin Substitutes by Countries
      • 9.1.1 Central & South America Tissue Engineered Skin Substitutes Sales by Countries
      • 9.1.2 Central & South America Tissue Engineered Skin Substitutes Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Tissue Engineered Skin Substitutes by Product
    • 9.3 Central & South America Tissue Engineered Skin Substitutes by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Tissue Engineered Skin Substitutes by Countries
      • 10.1.1 Middle East and Africa Tissue Engineered Skin Substitutes Sales by Countries
      • 10.1.2 Middle East and Africa Tissue Engineered Skin Substitutes Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Tissue Engineered Skin Substitutes by Product
    • 10.3 Middle East and Africa Tissue Engineered Skin Substitutes by End User

    11 Company Profiles

    • 11.1 Amarantus BioScience Holdings
      • 11.1.1 Amarantus BioScience Holdings Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Amarantus BioScience Holdings Tissue Engineered Skin Substitutes Products Offered
      • 11.1.5 Amarantus BioScience Holdings Recent Development
    • 11.2 Acelity L.P., Inc.
      • 11.2.1 Acelity L.P., Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Acelity L.P., Inc. Tissue Engineered Skin Substitutes Products Offered
      • 11.2.5 Acelity L.P., Inc. Recent Development
    • 11.3 BSN medical
      • 11.3.1 BSN medical Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BSN medical Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BSN medical Tissue Engineered Skin Substitutes Products Offered
      • 11.3.5 BSN medical Recent Development
    • 11.4 Integra LifeSciences Corporation
      • 11.4.1 Integra LifeSciences Corporation Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Integra LifeSciences Corporation Tissue Engineered Skin Substitutes Products Offered
      • 11.4.5 Integra LifeSciences Corporation Recent Development
    • 11.5 Medtronic (Covidien)
      • 11.5.1 Medtronic (Covidien) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Medtronic (Covidien) Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Medtronic (Covidien) Tissue Engineered Skin Substitutes Products Offered
      • 11.5.5 Medtronic (Covidien) Recent Development
    • 11.6 Molnlycke Health Care
      • 11.6.1 Molnlycke Health Care Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Molnlycke Health Care Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Molnlycke Health Care Tissue Engineered Skin Substitutes Products Offered
      • 11.6.5 Molnlycke Health Care Recent Development
    • 11.7 Smith & Nephew plc
      • 11.7.1 Smith & Nephew plc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Smith & Nephew plc Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Smith & Nephew plc Tissue Engineered Skin Substitutes Products Offered
      • 11.7.5 Smith & Nephew plc Recent Development
    • 11.8 Organogenesis, Inc
      • 11.8.1 Organogenesis, Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Organogenesis, Inc Tissue Engineered Skin Substitutes Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Organogenesis, Inc Tissue Engineered Skin Substitutes Products Offered
      • 11.8.5 Organogenesis, Inc Recent Development

    12 Future Forecast

    • 12.1 Tissue Engineered Skin Substitutes Market Forecast by Regions
      • 12.1.1 Global Tissue Engineered Skin Substitutes Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Tissue Engineered Skin Substitutes Revenue Forecast by Regions 2019-2025
    • 12.2 Tissue Engineered Skin Substitutes Market Forecast by Product
      • 12.2.1 Global Tissue Engineered Skin Substitutes Sales Forecast by Product 2019-2025
      • 12.2.2 Global Tissue Engineered Skin Substitutes Revenue Forecast by Product 2019-2025
    • 12.3 Tissue Engineered Skin Substitutes Market Forecast by End User
    • 12.4 North America Tissue Engineered Skin Substitutes Forecast
    • 12.5 Europe Tissue Engineered Skin Substitutes Forecast
    • 12.6 Asia Pacific Tissue Engineered Skin Substitutes Forecast
    • 12.7 Central & South America Tissue Engineered Skin Substitutes Forecast
    • 12.8 Middle East and Africa Tissue Engineered Skin Substitutes Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Tissue Engineered Skin Substitutes Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Tissue Engineered Skin Substitutes market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tissue Engineered Skin Substitutes market based on company, product type, end user and key regions.

      This report studies the global market size of Tissue Engineered Skin Substitutes in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tissue Engineered Skin Substitutes in these regions.
      This research report categorizes the global Tissue Engineered Skin Substitutes market by top players/brands, region, type and end user. This report also studies the global Tissue Engineered Skin Substitutes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Amarantus BioScience Holdings
      Acelity L.P., Inc.
      BSN medical
      Integra LifeSciences Corporation
      Medtronic (Covidien)
      Molnlycke Health Care
      Smith & Nephew plc
      Organogenesis, Inc

      Market size by Product
      Acellular
      Cellular Allogeneic
      Cellular Autologous
      Others
      Market size by End User
      Burn Injury
      Diabetic
      Vascular Ulcer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Tissue Engineered Skin Substitutes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Tissue Engineered Skin Substitutes market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Tissue Engineered Skin Substitutes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Tissue Engineered Skin Substitutes submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Tissue Engineered Skin Substitutes are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tissue Engineered Skin Substitutes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now